Zhuang Su,Zhengyu Long,Zhennian Huang,Suizhou Yang
申请号：
US15843729
公开号：
US10647747B2
申请日:
2017.12.15
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a compound of the Formula (I)):or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification； a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.
